|
Delayed
OTC Markets
19:31:54 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0145 USD | +1.05% |
|
+3.57% | -76.38% |
| 08-13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 3.24M 2.88M 2.67M 2.43M 4.58M 308M 4.66M 32.09M 12.58M 160M 12.16M 11.9M 512M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.96M 4.41M 4.09M 3.72M 7.01M 471M 7.13M 49.11M 19.25M 246M 18.61M 18.21M 783M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +1.05% | ||
| 1 week | +3.57% | ||
| Current month | +15.08% | ||
| 1 month | +11.54% | ||
| 3 months | -29.27% | ||
| 6 months | -50.00% | ||
| Current year | -76.38% |
| 1 week | 0.01 |  | 0.02 |
| 1 month | 0.01 | | 0.02 |
| Current year | 0.01 | | 0.1 |
| 1 year | 0.01 | | 0.1 |
| 3 years | 0.01 | | 0.1 |
| 5 years | 0.01 | | 0.26 |
| 10 years | 0.01 | | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 30/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 14/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 30/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 20/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 20/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/02/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | +3.57% | -65.14% | -63.48% | 3.24M | |
| +0.27% | +6.17% | +52.80% | +103.04% | 1,116B | |
| +0.84% | -2.28% | +32.98% | +62.18% | 610B | |
| +0.83% | +3.28% | +25.87% | +93.95% | 501B | |
| +0.82% | +0.64% | +74.61% | +40.71% | 358B | |
| -0.13% | +5.98% | +32.91% | +50.39% | 366B | |
| -0.95% | +4.70% | +19.51% | +43.00% | 288B | |
| -1.98% | +3.73% | -0.86% | +13.43% | 261B | |
| -0.24% | +4.30% | +46.28% | +50.83% | 235B | |
| -0.82% | +3.21% | +32.40% | +97.01% | 195B | |
| Average | -0.07% | +4.99% | +25.14% | +49.11% | 392.98B | |
| Weighted average by Cap. | +0.09% | +4.93% | +39.02% | +71.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.96M 12.94M 11.77M 22.22M 1.49B 22.57M 156M 60.98M 778M 58.94M 57.69M 2.48B | 13.79M 12.26M 11.36M 10.34M 19.5M 1.31B 19.82M 137M 53.54M 683M 51.75M 50.65M 2.18B |
| Net income | -2.39M -2.13M -1.97M -1.79M -3.39M -227M -3.44M -23.71M -9.3M -119M -8.98M -8.79M -378M | -958K -852K -789K -718K -1.36M -90.92M -1.38M -9.49M -3.72M -47.45M -3.6M -3.52M -151M |
| Net Debt | 325K 289K 268K 244K 460K 30.84M 467K 3.22M 1.26M 16.1M 1.22M 1.19M 51.31M | 1.72M 1.53M 1.42M 1.29M 2.43M 163M 2.47M 17.01M 6.67M 85.09M 6.45M 6.31M 271M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | US$0.0145 | +1.05% | 25,156 |
| 15/10/26 | US$0.0144 | -4.33% | 104,639 |
| 14/10/26 | US$0.0150 | +4.17% | 92,619 |
| 13/10/26 | US$0.0144 | +6.67% | 74,502 |
| 12/10/26 | US$0.0135 | -3.57% | 215,863 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
